FINDEX Inc. (TYO:3649)
Japan · Delayed Price · Currency is JPY | Market Cap | 20.01B +9.2% |
| Revenue (ttm) | 6.11B +4.6% |
| Net Income | 1.26B +8.1% |
| EPS | 50.03 +10.5% |
| Shares Out | 24.41M |
| PE Ratio | 16.39 |
| Forward PE | 15.16 |
| Dividend | 27.00 (3.29%) |
| Ex-Dividend Date | Jun 29, 2026 |
| Volume | 63,000 |
| Average Volume | 71,845 |
| Open | 836.00 |
| Previous Close | 836.00 |
| Day's Range | 819.00 - 844.00 |
| 52-Week Range | 680.00 - 1,011.00 |
| Beta | 0.38 |
| RSI | 43.85 |
| Earnings Date | May 14, 2026 |
About FINDEX
FINDEX Inc. offers medical devices in Japan. It operates through three segments: Medical Business, Public Business, and Healthtech Business. The company provides Claio image filing system, C-Scan paper and digital document management system, DocuMaker document creation system, PDI+MoveBy referral information management system, C-Note medical record writing system, MapleNote perinatal system, REMORA electronic medical record, ID-Cam/Claio-Cam digital camera solution, UniversalSearcher medical big data search system, FAXde regional collaboration ... [Read more]
Financial Performance
In 2025, FINDEX's revenue was 6.11 billion, an increase of 4.59% compared to the previous year's 5.84 billion. Earnings were 1.26 billion, an increase of 8.09%.
Financial StatementsNews
PE-backed Findex set to restock coffers with $400m refinancing
Skye Capital is expected to spend the coming weeks collecting feedback from funds on the deal structure, including size and pricing.